Stay updated on FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Sign up to get notified when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.

Latest updates to the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page now displays the completed FURI study record, including its design, eligibility criteria, outcome measures, record dates, and study documents, rather than a 403 error screen.SummaryDifference75%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a 403 Forbidden message, replacing the study details and navigation. This indicates an access/permission issue that hides the NCT03059992 study content from the page.SummaryDifference19%

Stay in the know with updates to FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Enter your email address, and we'll notify you when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.